BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 37068591)

  • 1. β-Propiolactone (BPL)-inactivation of SARS-Co-V-2: In vitro validation with focus on saliva from COVID-19 patients for scent dog training.
    Pilchová V; Prajeeth CK; Jendrny P; Twele F; Meller S; Pink I; Fathi A; Addo MM; Volk HA; Osterhaus A; von Köckritz-Blickwede M; Schulz C
    J Virol Methods; 2023 Jul; 317():114733. PubMed ID: 37068591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of SARS-CoV-2 by β-propiolactone causes aggregation of viral particles and loss of antigenic potential.
    Gupta D; Parthasarathy H; Sah V; Tandel D; Vedagiri D; Reddy S; Harshan KH
    Virus Res; 2021 Nov; 305():198555. PubMed ID: 34487766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the beta-propiolactone sensitivity and optimization of inactivation methods for human influenza H3N2 virus.
    Sasaki Y; Yoshino N; Sato S; Muraki Y
    J Virol Methods; 2016 Sep; 235():105-111. PubMed ID: 27142111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scent dog identification of SARS-CoV-2 infections in different body fluids.
    Jendrny P; Twele F; Meller S; Schulz C; von Köckritz-Blickwede M; Osterhaus ADME; Ebbers H; Ebbers J; Pilchová V; Pink I; Welte T; Manns MP; Fathi A; Addo MM; Ernst C; Schäfer W; Engels M; Petrov A; Marquart K; Schotte U; Schalke E; Volk HA
    BMC Infect Dis; 2021 Jul; 21(1):707. PubMed ID: 34315418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA.
    Kulkarni R; Patil HP; Palkar S; Lalwani S; Mishra AC; Arankalle V
    J Virol Methods; 2021 Jan; 287():113996. PubMed ID: 33126149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments.
    Yu S; Wei Y; Liang H; Ji W; Chang Z; Xie S; Wang Y; Li W; Liu Y; Wu H; Li J; Wang H; Yang X
    Viruses; 2022 Aug; 14(9):. PubMed ID: 36146745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluated in a murine model.
    de Castro Barbosa E; de Souza Andrade A; Duarte MM; Faria G; de Melo Iani FC; Ataide ACZ; Cunha LM; Duarte CG; Fialho SL; Caldas S
    Mol Immunol; 2022 Jul; 147():199-208. PubMed ID: 35644072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 inactivation in laboratory animal tissues with 4% formaldehyde or 5% glutaraldehyde for transfer to biosafety level 1 laboratories.
    Pilchová V; Elmontaser Mergani A; Clever S; Ciurkiewicz M; Becker K; Gerhauser I; Baumgärtner W; Volz A; von Köckritz-Blickwede M; Schulz C
    Vet Pathol; 2024 Mar; 61(2):201-206. PubMed ID: 37698272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-Propiolactone Inactivation of Coxsackievirus A16 Induces Structural Alteration and Surface Modification of Viral Capsids.
    Fan C; Ye X; Ku Z; Kong L; Liu Q; Xu C; Cong Y; Huang Z
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and Immunoreactivity Properties of the SARS-CoV-2 Spike Protein upon the Development of an Inactivated Vaccine.
    Kordyukova LV; Moiseenko AV; Serebryakova MV; Shuklina MA; Sergeeva MV; Lioznov DA; Shanko AV
    Viruses; 2023 Feb; 15(2):. PubMed ID: 36851694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of different inactivation methods for high and low pathogenic avian influenza viruses in egg-fluids for antigen preparation.
    Pawar SD; Murtadak VB; Kale SD; Shinde PV; Parkhi SS
    J Virol Methods; 2015 Sep; 222():28-33. PubMed ID: 25997377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation of betapropiolactone (BPL) as an inactivant for infectious bovine rhinotracheitis (IBR) virus.
    Kamaraj G; Lakshmi Narasu M; Srinivasan VA
    Res Vet Sci; 2008 Dec; 85(3):589-94. PubMed ID: 18262212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivated or damaged? Comparing the effect of inactivation methods on influenza virions to optimize vaccine production.
    Herrera-Rodriguez J; Signorazzi A; Holtrop M; de Vries-Idema J; Huckriede A
    Vaccine; 2019 Mar; 37(12):1630-1637. PubMed ID: 30765167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of viral inactivation methods on the characteristics of extracellular vesicles from SARS-CoV-2 infected human lung epithelial cells.
    Kongsomros S; Pongsakul N; Panachan J; Khowawisetsut L; Somkird J; Sangma C; Kanjanapruthipong T; Wongtrakoongate P; Chairoungdua A; Pattanapanyasat K; Newburg DS; Morrow AL; Hongeng S; Thitithanyanont A; Chutipongtanate S
    J Extracell Vesicles; 2022 Dec; 11(12):e12291. PubMed ID: 36468940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discrimination of SARS-CoV-2 infected patient samples by detection dogs: A proof of concept study.
    Essler JL; Kane SA; Nolan P; Akaho EH; Berna AZ; DeAngelo A; Berk RA; Kaynaroglu P; Plymouth VL; Frank ID; Weiss SR; Odom John AR; Otto CM
    PLoS One; 2021; 16(4):e0250158. PubMed ID: 33852639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of chemical inactivation of bovine viral diarrhea virus with beta-propiolactone and binary ethyleneimine on plasma proteins and coagulation factors.
    Refaie FM; Esmat AY; Mohamed AF; Mohamed WA
    Egypt J Immunol; 2004; 11(2):9-20. PubMed ID: 16734113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humidity and Deposition Solution Play a Critical Role in Virus Inactivation by Heat Treatment of N95 Respirators.
    Rockey N; Arts PJ; Li L; Harrison KR; Langenfeld K; Fitzsimmons WJ; Lauring AS; Love NG; Kaye KS; Raskin L; Roberts WW; Hegarty B; Wigginton KR
    mSphere; 2020 Oct; 5(5):. PubMed ID: 33087516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 scent dog research highlights and synthesis during the pandemic of December 2019-April 2023.
    Dickey T; Junqueira H
    J Osteopath Med; 2023 Oct; 123(11):509-521. PubMed ID: 37452676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivation of DNA by beta-propiolactone.
    Perrin P; Morgeaux S
    Biologicals; 1995 Sep; 23(3):207-11. PubMed ID: 8527119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sample-Treatment with the Virucidal β-Propiolactone Does Not Preclude Analysis by Large Panel Affinity Proteomics, Including the Discovery of Biomarker Candidates.
    Beutgen VM; Bhagwat AM; Steitz AM; Reinartz S; Müller R; Graumann J
    Anal Chem; 2024 Jun; 96(23):9332-9342. PubMed ID: 38810147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.